PharmaShots | Incisive News in 3 Shots

Subscribe Now

Chronic Inflammatory Conditions

Insights+ Key Biosimilars Events of August 2024

Insights+ Key Biosimilars Events of August 2024

September 3, 2024

Celltrion’s Steqeyma (Biosimilar, Stelara) Receives the Health Canada’s Approval to Treat Various Chronic Inflammatory Conditions

Celltrion’s Steqeyma (Biosimilar, Stelara) Receives the Health Canada’s Approval to Treat Various Chronic Inflammatory Conditions

August 2, 2024

Pfizer Reports the US FDA’s Acceptance for Review the Prior Approval Supplement to the BLA for Abrilada (biosimilar, adalimumab) to Treat of Chronic Inflammatory Conditions

Pfizer Reports the US FDA’s Acceptance for Review the Prior Approval Supplement to the BLA for Abrilada (biosimilar, adalimumab) t...

February 25, 2022

Contact Us

First Floor, B-66, Sector 63 Noida, Uttar Pradesh, INDIA - 201301
+91-120 428 0707
connect@pharmashots.com
Newsletter

Our Information

Follow Us